Hyperoxaluria and Tubule Injury and Kidney Stone Disease

高草酸尿症、肾小管损伤和肾结石病

基本信息

  • 批准号:
    6555901
  • 负责人:
  • 金额:
    $ 12.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-03-01 至 2005-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Kidney stone disease is a substantial health problem associated with significant pain, suffering, and economic costs. 5% to 15% of the population will have a symptomatic episode of a stone by the age of 70 and at least 50% of these individuals will have recurrent disease. To date, urolithiasis researchers have been limited to cell culure studies or a rat model where hyperoxaluria is induced by either ethylene glycol oral administration that is toxic to multiple organs or by high dose intraperitoneal sodium oxalate injection. The levels of induced urinary oxalate excretion in the rat needed to produce oxalate crystalluria and tisssue or cell response are criticized as being supraphysiologic compared to man. We propose that the pig is ideal for the development of an animal model of calcium oxalate crystalluria and calcium oxalate stone disease. The anatomy and physiology of the pig kidney is very similar to man. The anerobic bacteria Oxalobacter formigenes degrades oxalate to formate in the pig gut and normally stops the pig from becoming hyperoxaluric. We have successfully obtained Oxalobacter formigenes free pigs and report here for the first time that these pigs demonstrated a significant increase in urinary oxalate excretion as the result of an oral oxalate load similar to that experienced by man ingesting an oxalate rich diet. We propose to induce hyperoxaluria in the pig by feeding them an oxalate rich diet. We propose to study the effect of hyperoxaluria on pig kidney physiology and its impact on calcium oxalate crystal attachment and stone maturation. We hypothesize that pigs fed oxalate will form calcium oxalate crystalluria and calcium oxalate stones in their urinary tract in a manner very similar to man. We also hypothesize that these hyperoxaluric pigs are ideally suited for the extension of studies on the effect of hyperoxaluria on renal epithelial cell physiology, crystal attachment and stone maturation. This grant proposal contains three Specific Aims that test our hypotheses:Specific Aim I: To develop a new hyperoxaluric pig animal model.Specific Aim II: To initiate calcium oxalate crystalluria in the pig and to identify the site of crystal attachment along the nephron.Specific Aim III: To induce calcium oxalate stone disease in the pig and to characterize the process of stone maturation. These Specific Aims and their associated questions will allow us to fully describe the development of hyperoxaluria in the pig and the development of calcium oxalate crystalluria and calcium oxalate stones. The hyperoxaluric pig will have great potential in the advancement of many areas of urolithiasis research and in the design of new therapeutic modalities for the treatment of stone disease.
描述(由申请人提供):肾结石疾病是一种严重的健康问题,与严重的疼痛,痛苦和经济成本相关。 5%至15%的人口在70岁时会出现结石症状,其中至少50%的人会复发。迄今为止,尿石症的研究人员一直局限于细胞培养研究或大鼠模型,其中高尿酸是由乙二醇口服给药,这是有毒的多器官或高剂量的腹膜内注射草酸钠诱导。与人类相比,大鼠产生草酸盐结晶和组织或细胞反应所需的诱导尿草酸盐排泄水平被批评为超生理。 我们认为,猪是理想的动物模型,草酸钙晶体和草酸钙结石病的发展。猪肾脏的解剖和生理结构与人类非常相似。厌氧细菌Oxalactiniformigenes在猪肠中将草酸盐降解为甲酸盐,通常会阻止猪患高尿酸症。我们已经成功地获得了无草酸杆菌的猪,并在此首次报道,这些猪表现出尿草酸排泄的显著增加,这是由于口服草酸负荷与富含草酸的人类饮食所经历的类似。我们建议通过给猪喂食富含草酸盐的饮食来诱导高尿酸血症。我们拟研究高尿酸对猪肾脏生理的影响及其对草酸钙晶体附着和结石成熟的影响。 我们假设,猪喂草酸盐将形成草酸钙结晶和草酸钙结石在他们的尿路中的方式非常相似的man.We还假设,这些高尿酸的猪是理想的适合高尿酸对肾上皮细胞生理学,晶体附着和结石成熟的影响的研究扩展。该资助提案包含三个具体目标来验证我们的假设:具体目标I:开发一种新的高草酸尿猪动物模型。具体目标II:在猪中引发草酸钙结晶尿并确定晶体附着的位置。沿着肾单位。具体目标III:诱导猪的草酸钙结石疾病并描述结石成熟过程。 这些特定目的及其相关问题将使我们能够充分描述猪高尿酸的发展以及草酸钙晶体和草酸钙结石的发展。高尿酸猪将在尿石症研究的许多领域的进步和结石病治疗的新治疗方式的设计方面具有巨大的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NEIL S. MANDEL其他文献

NEIL S. MANDEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NEIL S. MANDEL', 18)}}的其他基金

Afferent arteriolar function and novel small molecules for renal radiation injury
入球小动脉功能和新型小分子治疗肾放射损伤
  • 批准号:
    9232964
  • 财政年份:
    2014
  • 资助金额:
    $ 12.6万
  • 项目类别:
Afferent arteriolar function and novel small molecules for renal radiation injury
入球小动脉功能和新型小分子治疗肾放射损伤
  • 批准号:
    8974351
  • 财政年份:
    2014
  • 资助金额:
    $ 12.6万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    6668065
  • 财政年份:
    2003
  • 资助金额:
    $ 12.6万
  • 项目类别:
Hyperoxaluria Leading to Tubule Injury and Kidney Stone Disease
高草酸尿症导致肾小管损伤和肾结石病
  • 批准号:
    6706400
  • 财政年份:
    2003
  • 资助金额:
    $ 12.6万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    7240567
  • 财政年份:
    2003
  • 资助金额:
    $ 12.6万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    6899909
  • 财政年份:
    2003
  • 资助金额:
    $ 12.6万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    6786585
  • 财政年份:
    2003
  • 资助金额:
    $ 12.6万
  • 项目类别:
Genetic Linkages in Calcium Oxalate Stone Disease
草酸钙结石病的遗传联系
  • 批准号:
    7074768
  • 财政年份:
    2003
  • 资助金额:
    $ 12.6万
  • 项目类别:
CRYSTAL-MEMBRANE INTERACTIONS IN SILICOSIS
硅肺病中的晶膜相互作用
  • 批准号:
    3340945
  • 财政年份:
    1985
  • 资助金额:
    $ 12.6万
  • 项目类别:
CRYSTAL-MEMBRANE INTERACTIONS IN SILICOSIS
硅肺病中的晶膜相互作用
  • 批准号:
    3340944
  • 财政年份:
    1985
  • 资助金额:
    $ 12.6万
  • 项目类别:

相似海外基金

CAREER: Unveiling the structure and stability of prenucleation clusters and their roles in crystallization pathway and final crystal structure
职业:揭示成核前团簇的结构和稳定性及其在结晶途径和最终晶体结构中的作用
  • 批准号:
    2338173
  • 财政年份:
    2024
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Continuing Grant
CAREER: Nanoscale Resolution of Near-Interface Crystallization in Multicomponent Semicrystalline Polymeric Materials
职业:多组分半晶聚合物材料中近界面结晶的纳米级分辨率
  • 批准号:
    2338613
  • 财政年份:
    2024
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Continuing Grant
CAREER: Evaluating Theories of Polymer Crystallization by Directly Calculating the Nucleation Barrier in a Polymer Melt
职业:通过直接计算聚合物熔体中的成核势垒来评估聚合物结晶理论
  • 批准号:
    2338690
  • 财政年份:
    2024
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Continuing Grant
Anti-solvent crystallization及び ED-Rプロセスを用いる新規LiB再生システムの構築
采用反溶剂结晶和ED-R工艺构建新型LiB再生系统
  • 批准号:
    24K08133
  • 财政年份:
    2024
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of the active fiber-type device by glass crystallization for next-generation light control
通过玻璃结晶创建用于下一​​代光控制的有源光纤型装置
  • 批准号:
    22KJ0290
  • 财政年份:
    2023
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Understanding Plant Based Fat Crystallization for the Design of Vegan and Low Carbon Footprint Chocolate
了解植物脂肪结晶在纯素和低碳足迹巧克力设计中的应用
  • 批准号:
    BB/Y512692/1
  • 财政年份:
    2023
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Training Grant
General applicability and quantitative predictability of complex population-based crystallization models
基于复杂群体的结晶模型的普遍适用性和定量可预测性
  • 批准号:
    2903595
  • 财政年份:
    2023
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Studentship
Elucidation of the origin of zeolite crystallization and innovation of production methods
沸石结晶起源的阐明及生产方法的创新
  • 批准号:
    23H05454
  • 财政年份:
    2023
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Biopharmaceuticals purification by continuous membrane-assisted crystallization achieving lower cost and intensified processes (BIOPURE)
通过连续膜辅助结晶进行生物制药纯化,实现更低的成本和强化工艺 (BIOPURE)
  • 批准号:
    10082780
  • 财政年份:
    2023
  • 资助金额:
    $ 12.6万
  • 项目类别:
    EU-Funded
Development of a Novel Method for Producing Pharmaceutical Multi-Phase Solid Using Melt Crystallization
开发利用熔融结晶生产药物多相固体的新方法
  • 批准号:
    23KJ0860
  • 财政年份:
    2023
  • 资助金额:
    $ 12.6万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了